Improving soft tissue restoration using a new injectable material
Characterization and Optimization of a Nanofiber-Hydrogel Composite for Tissue Remodeling
['FUNDING_FELLOWSHIP'] · JOHNS HOPKINS UNIVERSITY · NIH-10817017
This study is testing a new injectable material that helps heal soft tissue by working with your body's natural healing processes, and it's designed for people who need help with tissue repair.
Quick facts
| Phase | ['FUNDING_FELLOWSHIP'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | JOHNS HOPKINS UNIVERSITY (nih funded) |
| Locations | 1 site (BALTIMORE, UNITED STATES) |
| Trial ID | NIH-10817017 on ClinicalTrials.gov |
What this research studies
This research focuses on developing an injectable nanofiber-hydrogel composite that aims to restore soft tissue by promoting natural remodeling. The approach involves characterizing how this material interacts with the immune system and tissue over time, including how it encourages the growth of blood vessels and fat cells. By understanding the mechanisms behind its effectiveness, the researchers hope to optimize the formulation for better outcomes in tissue repair. This could provide a more reliable and effective option for patients needing soft tissue restoration.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals requiring soft tissue restoration due to injury, surgery, or other medical conditions.
Not a fit: Patients with conditions that do not involve soft tissue loss or those who are not candidates for tissue restoration procedures may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved methods for restoring soft tissue, reducing complications and enhancing healing for patients.
How similar studies have performed: Other research has shown promise in using biomaterials for tissue engineering, indicating that this approach could be a significant advancement in the field.
Where this research is happening
BALTIMORE, UNITED STATES
- JOHNS HOPKINS UNIVERSITY — BALTIMORE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: STELZEL, JESSICA — JOHNS HOPKINS UNIVERSITY
- Study coordinator: STELZEL, JESSICA
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.